文献速递心律失常

植入型心电监测仪在60岁以上不明原因晕厥患者中的诊断与干预价值

[Diagnostic and intervention value of implantable cardiac monitor in patients over 60 years of age with unexplained syncope].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2024-01-01

该多中心前瞻性队列研究纳入198例60岁以上不明原因晕厥患者,比较植入型心电监测仪(ICM)植入组与传统随访组。结果显示ICM组心原性晕厥诊断率(42.0% vs. 4.1%)和干预率(37.0% vs. 2.0%)均显著更高,ICM植入、既往房颤、糖尿病或基线一度房室传导阻滞是独立预测因素。

要点

  • ICM显著提高60岁以上不明原因晕厥患者的心原性晕厥诊断率(42.0% vs. 4.1%)。
  • ICM组治疗干预率也显著高于传统随访组(37.0% vs. 2.0%)。
  • ICM植入、既往房颤、糖尿病或基线一度房室传导阻滞为独立预测因素。

核心结论

  • ICM植入提高了60岁以上不明原因晕厥患者的诊断率和干预率,显著增加诊断效率。

研究设计与样本

  • 多中心、前瞻性队列研究,纳入2018年6月至2021年4月北京医院、阜外医院、北京安贞医院、普仁医院的60岁以上不明原因晕厥患者198例。
  • 依据是否自愿接受ICM植入分为植入组(100例)和传统随访组(98例),随访558.0(296.0,877.0)d。

主要发现

  • 植入组心原性晕厥诊断率为42.0%(42/100),传统随访组为4.1%(4/98),P<0.001。
  • 植入组治疗干预率为37.0%(37/100),传统随访组为2.0%(2/98),P<0.001。
  • Kaplan-Meier分析显示植入组心原性晕厥累计诊断率更高(HR=11.66,95%CI 6.49~20.98,log-rank P<0.001)。
  • 多因素Cox回归显示ICM植入、既往心房颤动、糖尿病或基线心电图提示一度房室传导阻滞是独立预测因素(P均<0.05)。
  • 随访期间植入组58例(58.0%)患者记录到心律失常阳性事件。

临床怎么用

  • 对60岁以上不明原因晕厥患者,可考虑植入ICM以提高心原性晕厥的诊断率和干预率。
  • 既往房颤、糖尿病或基线一度房室传导阻滞的患者可能更易从ICM植入中获益。

局限性

  • 分组基于患者自愿选择,植入组年龄更大、合并症更多、基线一度房室传导阻滞比例更高且体重指数更低,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the value of implantable cardiac monitor (ICM) in the diagnosis and treatment of patients over 60 years old with unexplained syncope. Methods: This was a multi-center, prospective cohort study. Between June 2018 and April 2021, patients over the age of 60 with unexplained syncope at Beijing Hospital, Fuwai Hospital, Beijing Anzhen Hospital and Puren Hospital were enrolled. Patients were divided into 2 groups based on their decision to receive ICM implantation (implantation group and conventional follow-up group). The endpoint was the recurrence of syncope and cardiogenic syncope as determined by positive cardiac arrhythmia events recorded at the ICM or diagnosed during routine follow-up. Kaplan-Meier survival analysis was used to compare the differences of cumulative diagnostic rate between the 2 groups. A multivariate Cox regression analysis was performed to determine independent predictors of diagnosis of cardiogenic syncope in patients with unexplained syncope. Results: A total of 198 patients with unexplained syncope, aged (72.9±8.25) years, were followed for 558.0 (296.0,877.0) d, including 98 males (49.5%). There were 100 (50.5%) patients in the implantation group and 98 (49.5%) in the conventional follow-up group. Compared with conventional follow-up group, patients in the implantation group were older, more likely to have comorbidities, had a higher proportion of first degree atrioventricular block indicated by baseline electrocardiogram, and had a lower body mass index (all P<0.05). During the follow-up period, positive cardiac arrhythmia events were recorded in 58 (58.0%) patients in the ICM group. The diagnosis rate (42.0% (42/100) vs. 4.1% (4/98), P<0.001) and the intervention rate (37.0% (37/100) vs. 2.0% (2/98), P<0.001) of cardiogenic syncope in the implantation group were higher than those in the conventional follow-up group (all P<0.001). Kaplan-Meier survival analysis showed that the cumulative diagnostic rate of cardiogenic syncope was significantly higher in the implantation group than in the traditional follow-up group (HR=11.66, 95%CI 6.49-20.98, log-rank P<0.001). Multivariate analysis indicated that ICM implantation, previous atrial fibrillation, diabetes mellitus or first degree atrioventricular block in baseline electrocardiogram were independent predictors for cardiogenic syncope (all P<0.05). Conclusions: ICM implantation improves the diagnosis and intervention rates in patients with unexplained syncope, and increases diagnostic efficiency in patients with unexplained syncope. 目的: 探讨植入型心电监测仪在60岁以上不明原因晕厥患者中的诊疗价值。 方法: 该研究为多中心、前瞻性队列研究,纳入2018年6月至2021年4月于北京医院、阜外医院、北京安贞医院、普仁医院就诊的60岁以上不明原因晕厥患者。依据是否自愿接受植入型心电监测仪植入将入选患者分为植入组和传统随访组。终点事件为入组后再次发作晕厥,以及通过植入型心电监测仪记录的心律失常阳性事件判断或经传统随访检查后明确诊断心原性晕厥。使用Kaplan‐Meier生存分析比较两组间心原性晕厥累计诊断率差异。采用多因素Cox回归分析不明原因晕厥患者明确诊断心原性晕厥的独立预测因素。 结果: 共入选198例不明原因晕厥患者,年龄(72.9±8.25)岁,随访558.0(296.0,877.0)d,男性98例(49.5%)。植入组100例(50.5%),传统随访组98例(49.5%)。与传统随访组相比,植入组患者更高龄、更易发生合并症,基线心电图提示一度房室传导阻滞者占比更高,而体重指数更低(P均<0.05)。随访期间植入组共计58例(58.0%)患者的植入型心电监测仪记录到心律失常阳性事件。植入组心原性晕厥诊断率[42.0%(42/100)比4.1%(4/98),P<0.001]及治疗干预率[37.0%(37/100)比2.0%(2/98),P<0.001]均高于传统随访组。Kaplan‐Meier生存分析显示,与传统随访组相比较,植入组心原性晕厥累计诊断率更高,差异有统计学意义(HR=11.66,95%CI 6.49~20.98,log-rank P<0.001)。多因素Cox回归分析结果显示,植入型心电监测仪植入、既往心房颤动、糖尿病或基线心电图提示一度房室传导阻滞是不明原因晕厥患者明确诊断心原性晕厥的独立预测因素(P均<0.05)。 结论: 植入型心电监测仪提高了不明原因晕厥患者的诊断率和干预率,显著增加不明原因晕厥的诊断效率。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang R, Zhang YF, Zhang HC, et al. [Diagnostic and intervention value of implantable cardiac monitor in patients over 60 years of age with unexplained syncope]. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 39019827. doi:10.3760/cma.j.cn112148-20230906-00132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。